Neuraxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Neuraxis, Inc. (NRXS) on July 3, 2025, covering events occurring on July 1, 2025. The company is an emerging growth company incorporated in Delaware, with its principal executive offices in Carmel, Indiana.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data for a reporting period. Specific financial impacts disclosed include:
- Termination Payment Obligation: The Company agreed to pay Masimo Corporation $200,000 in cash.
- Payment Schedule: Two equal installments of $100,000 due on December 31, 2025, and June 30, 2026.
- Revenue Impact: The Company will cease receiving any licensing payments or revenue from the NSS-2 Bridge device following the termination.
Material Changes
The primary material change is the termination of the License and Collaboration Agreement originally entered into with Masimo Corporation on April 9, 2020. Under the new Termination Agreement:
- The exclusive, royalty-free license granted to Masimo for the NSS-2 Bridge device and related patents/trademarks is terminated.
- Neuraxis assumes a liability of $200,000 for products, assets, and intellectual property rights.
- Future revenue streams associated with the Masimo Bridge product are eliminated.
Guidance, Outlook, and Corporate Actions
The filing does not contain forward-looking financial guidance or management commentary regarding future earnings. However, it discloses the following corporate actions:
- Employee Stock Purchase Plan (ESPP): Effective July 1, 2025, the Board adopted the 2025 ESPP, allowing eligible employees to purchase common stock at a 15% discount via payroll deductions.
- Share Authorization: The plan authorizes the issuance of up to 100,000 shares, with an annual increase mechanism from 2026 through 2035 (lesser of 1% of outstanding stock or 100,000 shares).
- Stockholder Approval: Stockholder approval for the ESPP is required within 12 months of the adoption date.
Investor Verification Checklist
- Verify the impact of the $200,000 termination payment on the company's current cash position and liquidity.
- Confirm the total historical revenue generated from the Masimo license prior to termination to assess the magnitude of the lost revenue stream.
- Review the full text of the Termination Agreement (Exhibit 10.1) for any additional liabilities or conditions not summarized in the 8-K.
- Monitor the timeline for stockholder approval of the 2025 Employee Stock Purchase Plan.